BioSpace News Archive

On their own, cancer or diabetes can be debilitating and deadly. The two are common diseases with tremendous impact on health worldwide.

Zynex, Inc today announced that the company will report first quarter 2023 financial results on Thursday, April 27, 2023.

Ankyra Therapeutics, a pre-clinical-stage oncology company developing anchored immunotherapies to improve the therapeutic window for cytokine drugs, announced that it will be presenting data from a canine clinical trial of cANK-101 at the American Association for Cancer Research Annual Meeting being held April 14-19, 2023, in Orlando, FL.

Biotricity Inc., a leading medical diagnostic and consumer healthcare technology company, reported that it reached a record $12 million annualized revenue run rate in March 2023.

Why Life Science Tools? Life science tools refer to a range of equipment and technologies used in various scientific disciplines, including biology, chemistry, and medicine.

Satellos Bioscience Inc. (TSXV: MSCL) (“Satellos” or the “Company”), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated,

Apotex Inc. is pleased to announce that it has received a Drug Shortage Assistance Award from the U.S. Food and Drug Administration (FDA) in recognition of the company’s substantial efforts to resolve a shortage of varenicline tablets.

Specialty cancer diagnostics company Precipio, Inc., announces that Q1-2023 product revenues have surpassed product revenues during the two prior quarters of 2022, and exceed 50% of the entire year of 2022 product revenues of $1.4M.

NICO Corporation has awarded Arabinda Das, PhD, neuroscientist and neuro-oncology assistant professor at the Medical University of South Carolina, a $180,000 Investigator Initiated Study grant supporting the development of a new glioblastoma patient-derived xenograft model.

Noctrix Health announced that the U.S. Food and Drug Administration (FDA) has granted its De Novo request for the NTX100 Tonic Motor Activation (TOMAC) System to treat symptoms of moderate-severe RLS and improve sleep quality in patients refractory to medications.